GenSight Biologics
Identification
Instrument name
GENSIGHT BIOLOGICS
Symbol
SIGHT
ISIN code
FR0013183985
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Capitalization compartment
Compartment C
ICB
Biotechnology
Website address
http://www.gensight-biologics.com
Operation
IPO date
Qua 13/07/2016
IPO price
EUR 8.00
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 7.80 - EUR 9.20
Perfil da Empresa
GenSight Biologics S.A. specializes in the research and development of gene therapies for the treatment of mitochondrial diseases and eye neurodegeneratives.
At the end of 2023, the company had a portfolio of 2 products, including 1 in phase III clinical development (Lumevoq for the treatment of Leber's hereditary optic neuropathy) and 1 in phase I/II clinical development (GS030 for the treatment of retinitis pigmentosa).
Fonte:
Cofisem
-
Última atualização:
24 Feb 2025
Principais Executivos
| Chief Executive Officer | Laurence Rodriguez | ||||
| Administrative & Finance Director | Jan Eryk Umiastowski | ||||
| Chief Technology Officer | Scott T. Jeffers | ||||
| Fonte: Cofisem - Última atualização: 24 Feb 2025 | |||||
Números principais
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 1.267 | 2.582 | 5.276 | 4.394 | 700 |
| Income from ordinary activities | 2.964 | 4.865 | 7.709 | 7.158 | 4.910 |
| Operating income | -29.696 | -27.835 | -28.126 | -24.934 | -30.298 |
| Cost of financial indebtedness net | 3.152 | 2.650 | 2.166 | 1.717 | 389 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | -26.220 | -27.625 | -28.617 | -34.015 | -30.710 |
| Net income (Group share) | -26.220 | -27.625 | -28.617 | -34.015 | -30.710 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
| Fonte: Cofisem - Última atualização: 24 Feb 2025 | |||||